Table Of Content

JACC Vol. 22, No. 7 December 1993:2063-7 Author Index: Volume 22 Aarsland T, 975 Ash J, 1948 Berner A, 777 Burt RW, 1344 Cines M, 963 Abendschein DR, 296 Aurigemma GP, 1679 Bernstein V, 390 Burzynski JB, 1944 Cleman MW, 1033, 1641 Ackerman D, 459 Avitall B, 921, 1367 Berry VA, 1093 Butman SM, 968 Close P, 1080 Adams KF, 113A Azqueta M, 1795 Bersohn MM, 271 Butrous G, 1214 Cloutier DJ, 1155 Adams PC, 1338 Betriu A, 1795 Byrum CJ, 1944 Clozel J-P, 615 Adams R, 1961 Bianchi F, 1809 Clozel M, 615 Adamson R, 1574 Bach DS, 1389 Biblo LA, 1117 Coats A, 73 Aguirre FV, 381, 449 Bach RG, 449 Bichet D, 390 Cachera J-P, 151 Coats AJS, 172A Ahlberg AW, 1155 Bacharach S, 1961 Bichler J, 1080 Cahalan MK, 848 Codeca L, 99 Ahrens PJ, 1010 Bagley CW, 1418 Bigger JT, 952 Cain ME, 85, 733 Codega S, 1614 Akagi T, 1182, 1948 Bailey A, 1935 Bikkina M, 1111 Califf RM, 381, 1780 Cody RJ, 165A, 201A Akasaka T, 1647 Bailey AS, 1983 Bischoff P, 1193 Calkins H, 80, 1723 Cohen BJ, 1697 Akhtar M, 921, 1718 Bailey KR, 1283, 1684, 1921 Bjorklund G, 2014 Callans DJ, 746, 1135 Cohen DJ, 1052 Alboni P, 99, 1130, 1373 Bailey S, 1641 Blackstone EH, 183 Camerieri A, 1809 Cohen GI, 1359, 1935 Alderman EL, 1141 Baim DS, 1052 Blanck Z, 1718 Camerini F, 808 Cohen M, 1338 Alessio P, 1866 Baird MG, 1557 Bloomfield D, 952 Camici PG, 650, 1653 Cohen TJ, 1485 Alexander JC, 204A Baker CS, 1378 Boden WE, 361 Camm AJ, 550, 566 Cohn JN, 135A, 2059 Alexander RW, 129A Bakx ALM, 1016 Boheler KR, 30A Campbell RM, 594 Cohn LH, 946 Alison JF, 581 Ballard DJ, 1921 Bolognese L, 1809 Campbell SE, 1477 Colan SD, 201, 1105, 1953 Allen JW, 340 Ban T, 1621 Bonow RO, 635, 796 Canciani B, 633 Coleman EA, 201 Allman KC, 368, 1425 Bangdiwala SI, 14A Bor A, 2001 Cantalupi D, 1804 Colin L, 695 Almagor Y, 1887 Barbash GI, 707 Borowski DT, 751 Canver CC, 1553 Collen D, 407 Altieri A, 1804 Barber MJ, 1093 Bosch Z, 1795 Cao Q-L, 907 Collins R, 73 Amano K, 1175 Barbour MMF, 1155 Bottoni N, 1123 Cao T, 271 Colman RW, 1089 Amano W, 1175 Barnathan ES, 1004 Botvinick EH, 805 Cape EG, 1730 Colombo A, 1887 American College of Baron JM, 1033 Boullon F, 1060 Cappato R, 99 Colucci WS, 113A Cardiology Cardiac Barrabés JA, 1661 Bouras Y, 1075 Cardella CJ, 1552 Coma-Canella I, 399 Catheterization Barzilai B, 1170 Bourassa MG, 14A, 146A, Cardiopulmonary Comas J, 193 Committee, 629 Bashir Y, 550, 1335 1141 Resuscitation Working Come P, 498 American College of Basnight MA, 1972 Bourdarias J-P, 1399 Group University of Congenital Heart Surgeons Cardiology Cardiovascular Bassand J-P, 1075 Boutjdir M, 1214 California, San Francisco, Society, 183 Surgery Committee, 946 Bates E, 1389 Boyd H, 1653 1485 Conversano A, 1587 American College of Battinelli NJ, 1354 Brady P, 1378 Carlson MD, 1117 Conway M, 73 Cardiology Cardiovascular Battista S, 1679 Braith RW, 768 Carlson R, 1268 Cooper MJ, 1711 Technology Assessment Battler A, 2001 Branch KR, 1574 Carneiro R, 376 Corley SD, 1141 Committee, 948 Baudhuin T, 159 Brandt RR, 86A Caron J, 2061 Corra U, 1821 American College of Bauman WB, 2033 Braunsteiner H, 1897 Casanova JM, 695 Cossio J, 695 Cardiology Peripheral Baumbach A, 777 Braunwald E, 1763 CASS Participating Coulden R, 839 Vascular Disease Baustian A, 1972 Breall JA, 1052 Investigators Staff, 1141 Cowley AJ, 113A Committee, 626 Beanlands RS, 632 Bridges ND, 207 Castro Beiras JM, 399 Cowley MJ, 1289 Amino JG, 376 Beanlands RSB, 1389 Brignole M, 1123, 1130 Cave V, 665 Cox JL, 85 Ammon §S, 1598 Becher H, 521 Brinker JA, 1273 Celermajer DS, 854 Cox TA, 340 Amsterdam EA, 1738 Bednarz J, 839 Bristow MR, 61A, 1902 Chae SC, 665 Crake T, 1607, 1653 Anderson KP, 92 Bedotto JB, 690 Broder JD, 1730 Chaitman BR, 1141 Crawford M, 1269 Angelini C, 1927 Behrens P, 684 Broly F, 2061 Chamberlain D, 1338 Crea F, 1892 Angermann CE, 310 Beimpold H, 1897 Brooks MM, 998 Chambers RJ, 1044 Creager MA, 65 Angoli L, 1614 Bekheit S, 1214 Brooks R, 569, 1835 Chappell JH, 1751 Crew JR, 480 Anguenot T, 1075 Belkin M, 2001 Brouwer J, 1564 Chassagne C, 30A Crijns HJGM, 1666 Ansari AA, 1385 Bell CA, 449 Brozena SC, 113A Cheirif J, 1494 Crouse LJ, 1494 Antithrombotic Therapy in Belohlavek M, 1673 Brum J, 1983 Chen C, 1554 Cuddy TE, 390 Acute Coronary Benedict CR, 146A Bruniaux J, 193 Chen J-M, 1199 Cumberland DC, 480 Syndromes Research Benhorin J, 671 Bruschke AVG, 431, 1016 Cheng J-J, 1541 Cycan A, 1418 Group, 1338 Benowitz NL, 648, 1159 Brutsaert DL, 318 Cheriex EC, 758 Antonioli GE, 99 Benson LN, 873, 1182, 1948 Brzostek T, 407 Chesebro JH, 1338 Antony I, 151, 514 Benvenuti C, 151 Buffolo E, 376 Chiaranda G, 1809 Dae MW, 805 Aoki T, 1175 Beppu S, 575 Bugiardini R, 417 Chiarella F, 1809 Dagenais GR, 390 Appleby P, 73 Bergamaschi R, 1614 Buis B, 1016 Chiariello L, 1892 Daily PO, 1574 Appleton CP, 1972 Bergau DM, 1105 Buja GF, 1927 Chiku N, 727 Dalla Volta S, 1927 Aptecar E, 151, 514 Berger PB, 1773 Bulle TM, 1289 Chin W, 1598 Daly PA, 1552 Arakawa K, 790 Bergin JD, 251 Biller H, 1080 Chioin R, 1373 Danieli GA, 1927 Armando I, 1961 Bergman G, 168 Burch M, 1189 Chisholm R, 783 Danielson GK, 216 Armstrong PW, 891 Bergmann SR, 1587 Burg MM, 440 Choudhury L, 1653 Dark JH, 2059 Armstrong WF, 1389 Berk M, 113A Burkart F, 1446 Christian TF, 1311 Davignon A, 851 Arnold JM, 390 Berman DS, 1455 Burnett JC Jr., 86A Chryssos BE, 1854 Davila-Roman VG, 1170 Arntz R, 1304 Berman N, 106 Burns RJ, 632 Chu CK, 816 De Bruyne B, 119 Aronovitz M, 907 Bernard Y, 1075 Burrows PE, 873 Chung MK, 733 de Champlain J, 390 2064 AUTHOR INDEX VOLUME 22 JACC Vol. 22, No. 7 December 1993:2063-7 De Ferrari GM, 283, 1327 Edwards WD, 720, 1283 Fox KAA, 1338 Goldstein S, 1802 Hermosillo AG, 695 de Flores T, 1795 Egashira K, 144 Francis CK, 714 Gonzales MS, 1972 Herold M, 1897 De Geest H, 407 Ehler WJ, 2007 Francis M, 557, 1320 Gopal AS, 258 Herrington DM, 1068 de Roos A, 431 Eigler NL, 1207 Franzosi MG, 1788 Gordon JB, 1574 Herrmann HC, 783 de Silva R, 650, 1653 Eisenberg MJ, 588, 1581 Frederick MM, 1773 Gosselink ATM, 1666 Herscovitch P, 1961 de Swart H, 1755 Eisenberg PR, 1170 Freed M, 1628 Gottlieb SS, 390, 963 Herskowitz A, 1385 Dean LS, 1289 Eisenhofer G, 1961 Freedom RM, 183, 873, 1182, Gould KL, 984 Hess KR, 557, 1320 Deanfield JE, 854 Eisenmann B, 1193 1948 Grabicki JM, 113A Hess OM, 1477 DeGrado TR, 368, 632 El-Atassi R, 80 Friedman JD, 1455 Green M, 1948 Heyndrickx GR, 119 del Val Gémez Martinez M, Eldar M, 2001 Friedman RA, 95 Greenberg B, 146A Hideg A, 175 399 Elefteriades JA, 1411 Froelicher VF, 175 Greenberg H, 361 Hillege H, 1666 DeLacey WA, 1093 Elkayam U, 65, 139A Frohlich ED, 621 Greene DA, 1425 Hirakawa Y, 291 Delage F, 390 Ellis S, 1641 Fuca G, 1373 GreenleaJfF , 1673 Hirata K, 1621 Deleuze P, 151 Ellis SG, 376, 1289, 1780 Fujita M, 426, 1271 Gregorini L, 1866 Hirshfeld JW, 1641 Delia E, 816 El-Sherif N, 1214 Fujiwara H, 575 Grigera F, 1298 Hittinger L, 34A Deligoniil U, 1691 El-Zeky F, 508 Furuta Y, 727 Grima EA, 891 Ho DSW, 1711 DeMaria AN, 1530 Emslander HP, 521 Fuster V, 1338 Grimes RY, 1730 Ho KKL, 6A, 201A, 1052 Dembitsky WP, 1574 Engelberg S, 2001 Fyfe Al, 1552 Grimm RA, 1359 Hoagland PM, 1574 Denfield SW, 95 Enriquez-Sarano M, 1684 Grines CL, 1628 Hoeks APG, 1881 Deng Y-B, 1522 Epailly E, 1193 Gropler RJ, 1587 Hoet B, 1080 Denton TA, 343 Epstein LA, 542 Gaasch WH, 1679 Gross MD, 239 Hoffmann R, 529 DeQuattro V, 1438 Epstein SE, 635, 796 Gaballa M, 1972 Grossman E, 1961 Hohnloser SH, 2058 Deshpande S, 921, 1718 ERACI Group, 1060 Gaines P, 480 Grossman W, 49A Holmes C, 1961 Desvigne-Nickens P, 1763 Esposito C, 1892 Galassi AR, 1607 Grossoni M, 283 Holmes DR, 135 Detry J-M, 159 Essop MR, 826 Galligan L, 1552 Grover-McKay M, 832 Holmes DR Jr., 1283 Deutsch E, 1089 European Hirudin in Galloway JM, 1972 Grunze M, 468 Hombach V, 1554 Devereux RB, 1470, 1873 Thrombosis Group, 1080 Gamache MC, 733 Guardigli G, 99 Hood WB Jr., 154A Dhala A, 921, 1718 Evans GT Jr., 1581 Gamsu G, 588 Guasti L, 1614 Hook BG, 746, 1135 D’Hondt A-M, 159 Evans SA, 1268 Ganau A, 1873 Gurné O, 14A Hopfenspirger MR, 1311 Di Lenarda A, 808 Ewing S, 805 Gandolfo N, 1809 Guyatt GH, 185A Hornberger LK, 1953 Di Segni E, 2001 Ewy GA, 968 Ganz W, 2058 Horowitz JD, 581 Diamond GA, 340, 343 Gao Y-A, 873 Howard RJ, 891 Dianzumba SB, 127 Garan H, 569, 1835 Haase KK, 777 Hsu T-L, 907 DiBianco R, 1557 Faes FC, 1915 Garber CE, 1155 Haber HL, 251 Huckell VF, 1994 Dibner-Dunlap ME, 56A Falcone C, 1614 Gardin JM, 277 Haberey P, 1193 Hughes GRV, 1269 Dickstein K, 975 Falk RH, 1354 Garg R, 3A, 194A Hackett FK, 1344 Hull SS Jr., 1327 Diehl J, 907 Fananapazir L, 796 Gaspardone A, 1892 Hahn E, 968 Hummel JD, 1100, 1723 Dilsizian V, 796 Fanin M, 1927 Gasquez A, 376 Haines DE, 1093 Hunt SA, | DiMarco JP, 1093 Farish SJ, 1199 Gattone M, 1821 Hambrecht R, 468 Hutchins GD, 1425 Dimas AP, 1298 Farrukh HM, 1902 Gatzoylis KA, 1117 Hamer HPM, 1666 DIMT Study Group, 1564 Fasoli G, 1927 Gaum WE, 1944 Hamm P, 390 Dinelli M, 1130 Faxon DP, 1141 Gavish A, 671 Hammill SC, 720 Igarashi T, 1175 Diodati JG, 635 Fearnot NE, 135 Geltman EM, 1587 Handwerger D, 1902 Ikari Y, 727 Distante A, 2014 Feindel CM, 1552 Gentles TL, 867 Hanley FL, 183 Ikeda M, 790 Dittmann H, 777 Feldman AM, 1223, 1902 Geny B, 1193 Hanly DE, 1494 Imai Y, 859 Dodge HT, 714 Feldman MD, 251 George BS, 135, 381 Hanrath P, 529 Imparato A, 1821 Dohmen HJM, 1564 Feldman T, 783 Gerber TC, 1673 Hardy J, 106 Incorvati RL, 127 D’ Oliveira LG, 376 Fenrich AL, 95 Germano G, 1455 Hare J, 921, 1367 Ino H, 1465 Donohue BC, 127 Ferguson TB Jr., 85 Gersh BJ, 1311, 1921, 2060 Haronian HL, 1033 Inou T, 144 Donohue TJ, 449 Fields J, 1418 Geva T, 1501, 1953 Harper RW, 581 Investigators of the Dorado M, 695 Finci L, 1887 Ghali JK, 14A, 146A Harrison MC, 955 International Tissue Dorian P, 106 Firschke C, 521 Ghelardini G, 2014 Hartzler GO, 135, 690 Plasminogen Activator/ Doshi R, 277 Fischer S, 914 Gianfranchi L, 1123 Hasdai D, 2001 Streptokinase Mortality Dougias JS Jr., 629 Fischli W, 615 Giannuzzi P, 1821 Hashimoto M, 659 Trial, 707 Douglas PS, 221 Fischman DL, 1641 Gibbons RJ, 1311 Hasse C, 1723 Isber N, 1214 Dreifus LS, 948 Fishbein MC, 1207 Gibbs HH, 1273 Hata H, 291 Isenberg WM, 1752 Drew BJ, 741 Fisher LD, 1141 Giesler M, 1554 Hata K, 598 Ishikura F, 575 Driscoll DJ, 216 Fisher ML, 963 Gilday DL, 1948 Hauer K, 468 Iskandrian AS, 665 Dubourg O, 1399 Fitchett DH, 1909 Gillebert TC, 318 Havenith M, 758 Isner J, 783 Ducharme G, 851 Fitzgerald GA, 1159 Gimple LW, 251 Hayashi Y, 598 Isshiki T, 727 Dunn BB, 1961 Flachskampf FA, 529 Gin KG, 1994 Hayashida W, 1403 Iturralde P, 695 Dunn MJ, 1378 Flather M, 73 Ginzton LE, 271 Heald SC, 550 Dunn MM, 588 Fletcher MP, 1738 Gioffré PA, 1892 Heart Muscle Disease Study Dunselman PHJM, 1564 Floras JS, 72A Giordano A, 1821 Group, 808 Jackson G, 1835 Duprat RF®2, 376 Flores BT, 1135 Giorgi LV, 690 Hecht GM, 489 Jain A, 1816 Dwyer EM Jr., 361, 816 Foéx P, 899 GISSI-2 Investigators, 1788 Heidbiichel H, 407 Jain D, 440 Foley DA, 1673 Gistri R, 650 Heineking M-L, 1304 Jani H, 1214 Forman SA, 1763 Glaeser DH, 557, 1320 Heinrich RS, 1730 Janssens L, 407 EAMI Study Group, 1821 Forrester JS, 1207 Glantz SA, 1752 Heller GV, 1155 Jaski BE, 1574 Echo Persantine Italian Forycki F, 1304 Goldberg S, 1641 Henry WL, 277 Jazayeri M, 921, 1367, 1718 Cooperative (EPIC) Study Foster E, 848 Goldberg SL, 1887 Henthorn RW, 1117 Jenkins KJ, 201, 1105 Group, 1809 Foster ED, 1141 Goldberger AL, 557 Henzgen R, 1304 Jennison SH, 1552 Edwards BS, 830 Foult J-M, 514 Goldsmith RL, 952 Heo J, 665 Johns PC, 1044 Edwards JE, 830 Fournier A, 851 Goldstein DS, 1961 Heras M, 1795 Johnson WL, 690 JACC Vol. 22, No. 7 AUTHOR INDEX VOLUME 22 2065 December 1993:2063-7 Johnstone DE, 14A, 146A Kleinert S, 1501 Lesh MD, 542, 883 Marsch SCU, 899 Montgomery DG, 239 Johnstone J, 459 Kligfield P, 168 Lessila C, 921 Martin U, 914 Montieth M, 1389 Jolly MK, 955 Kloner RA, 302 Leung W-H, 1635 Martini B, 633 Moore CK, 1389 Jonas RA, 1953 Klues HG, 489 Levi E, 1411 Marwick T, 159 Morady F, 80, 1100, 1723 Jondeau G, 1399 Knapp E, 1897 Levine RA, 535, 1730 Maseri A, 1607 Morehead AJ, 1983 Jones DL, 607 Knatterud GL, 1763 Levy D, 6A, 1111 Massie BM, 65, 1598 Morgagni GL, 417 Jones RT, 1581 Knilans TK, 95 LeWinter MM, 751 Mata J, 1858 Morgan-Hughes NJ, 2059 Jones T, 1653 Knoebel SB, 331 Lhermitte M, 2061 Matas M, 1795 Mori M, 598 Joseph A, 459 Knopf WD, 1273 Li HG, 607, 1849 Matloff JM, 343 Moriel M, 671 Jue J, 1581 Kohl K, 1304 Libersa C, 2061 Matsumoto Y, 859 Morillo CA, 1843, 1849 Juran N, 1628 Kolody SM, 1509 Lichtenberg A, 1628 Matsuura H, 659 Morise AP, 340 Morris CK, 175 Konishi J, 1621 Lie KI, 1564, 1666, 1755 Matzer L, 1455 Morris G, 1320 Konstam MA, 43A Liebson PR, 998 May MA, 1628 Kahn JK, 690 Kool MJF, 1881 Liepmann D, 1522 Mayer JE Jr., 201, 207 Morrow WR, 2007 Mortelmans L, 407 Kajiyama G, 659 Kopelman PG, 1433 Ligon RW, 690 McBride R, 1338 Mostacciuolo ML, 1927 Kalberer B, 468 Kopin IJ, 1961 Lima JAC, 783 McCallister BD, 2033 Mottram CD, 216 Kalbfleisch SJ, 80, 1100, 1723 Kosinski EJ, 1273 Limacher MC, 768 McCans J, 390 Moura A, 1983 Kalil RAK, 1915 Kottke TE, 1168 Lin F-Y, 1541 McClellan JR, 1155 Moyé L, 390 Kalman JM, 1199 Kovach JA, 1024 Lincoff AM, 1780 McComb JM, 2059 Muan B, 1193 Kambara H, 1621 Kozan O, 1691 Linderer T, 1304 McConahay DR, 690 Mueller HS, 1763 Kaneshige AM, 1684 Kramer-Fox R, 1470 Lindsay BD, 85, 733 McDonald KM, 2059 Miiller-Brand J, 1446 Kannel WB, 6A Kraml P, 310 Lipicky RJ, 179A McEwan P, 390 Mullins CE, 2007 Kanth N, 588 Krause PB, 1280 Lipton M, 839 McGovern BA, 569, 1835 Multicenter Diltiazem Karsch KR, 777 Krayenbuehl HP, 1477 Littler WA, 113A McGovern TW, 1283 Postinfarction Trial Katritsis D, 550 Krendel S, 1679 Littman AB, 678 MclIntosh-Yellin NL, 741 Research Group, 361 Katz SD, 1399 Krikler DM, 633 Litvack F, 1207 McKenna W, 1189 Multivessel Angioplasty Katz SE, 221 Krishnan R, 805 Litwin SE, 49A McKenna WJ, 498 Prognosis Study (MAPS) Kavey R-EW, 1944 Kron IL, 1093 Liu P, 99A Medina N, 963 Group, 1289 Kawaguchi T, 175 Krone RJ, 361 Liu SCK, 271 Mehra A, 139A Muralidharan E, 1730 Kawamoto M, 1621 Krucoff MW, 127 Lo H-M, 1541 Mehta JL, 684 Murray RD, 1983 Keating M, 506 Krum D, 921, 1367 Lock JE, 207, 867, 1105 Mehta K, 277 Muzik O, 368 Keller AM, 258 Krumholz HM, 1697 Loisance D, 151 Melacini P, 1927 Myers GH, 1816 Kelly RA, 107A Ktibler W, 468 Lok DJA, 1564 Melin J, 159 Myers J, 175 Kemkes BM, 310 Kubo SA, 113A Lolli G, 1123, 1130 Melon PG, 632 Kennedy JW, 2033 Kuga T, 144, 291 Lombardi F, 951 Mendelson J, 1581 Kenny RA, 2059 Kukin ML, 963 Longhurst JC, 1738 Meneveau N, 1075 Nadeau C, 390 Kent KM, 1024 Kuntz RE, 1052 Longmore DB, 1515 Menozzi C, 1123, 1130 Nagata S, 575 Kereiakes D, 381 Kupersmith J, 459 Lopez JAG, 642 Meredith IT, 581 Nakanishi T, 859 Kereiakes DJ, 135, 2033 Kveselis DA, 1944 Lorusso R, 758 Mettauer B, 1193 Nakashima Y, 790 Kern KB, 968 Losay J, 193 Meyer A, 1755 Nakazawa M, 859 Kern MJ, 449 Lucas CMHB, 758 Michelassi C, 1809 Narahara KA, 65 Kerns RD, 440 L’Abbate A, 2014 Lucchese FA, 1915 Michels A, 1858 Nass D, 2001 Kerr CR, 2061 Labovitz AJ, 1494 Luke RA, 733 Michels HR, 1755 Nath S, 1093 Kersenovich S, 695 Lacour-Gayet F, 193 Mietus J, 557 National Heart Lung, and Khamashta MA, 1269 Lacroix D, 2061 Milani RV, 678 Blood Institute Working Khan M, 921, 1367 Lafont A, 1298 Macherey RS, 127 Miles WM, 1344 Group on Atrial Khorsandi MJ, 1207 Lakatos E, 635 Maclsaac Al, 1228 Miller HI, 1033 Fibrillation, 1830 Kiat H, 1455 Lamas G, 390 Maddahi J, 1455 Miller LW, 1552 Nava A, 633 Kienast J, 1080 Lammertsma AA, 1653 Magaia O, 1809 Mills K, 1411 Nesralla IA, 1915 Killip T, 1141 Landi P, 1809 Magata Y, 1621 Mills RM Jr., 768 Neumann DA, 1385 Kilner PJ, 1515 Lang RM, 839 Maggioni AP, 1788 Milrinone Multicenter Trials Nevola E, 2014 Kim YH, 1730 Langberg JJ, 80, 1100, 1723 Magrina J, 1795 Investigators, 113A Newell J, 1835 King DL, 258, 1530 Langer A, 1270 Maiello L, 1887 Minardi G, 1809 Newman D, 106 King DL Jr., 258 Larrabee P, 1902 Malik M, 566 Minor RL Jr., 642 Nguyen D, 277 King SB, 135 Larson MG, 1111 Malinverni C, 1821 Mintz GS, 1024 Nguyen N, 632 King SB III, 353, 2033 Latif N, 1378 Mall G, 1477 Miorelli M, 1927 Nicklas J, 146A Kinugawa T, 56A Latini R, 1788 Malliani A, 951 Mirvis DM, 508 Nicolini F, 684 Kiowski W, 1446 Lavie CJ, 678 Malloy MJ, 478 Mitchell J, 106 Niebauer J, 468 Kirk KL, 1961 Lawson D, 684 Maloney JD, 1359 Mitra RL, 1135 Niggel J, 751 Kirklin JW, 183 Lee DD-P, 1438 Man in ’t Veld AJ, 1564 Mitrani RD, 1117, 1344 Nihoyannopoulos P, 1653 Kirlin P, 146A Lee KL, 1780 Man KC, 1100, 1723 Miwa K, 426, 1271 Nii T, 790 Kirsh MM, 239 Lee RT, 498 Mancia G, 1866 Miyatake K, 575 Nikolic SD, 953 Kisslo JA, 1494 Lefroy DC, 1607, 1653 Mancini DM, 93A Modan M, 707 Nir A, 216 Kita Y, 1465 Leggett SH, 768 Manning WJ, 221 Moderator, 201A, 204A Nishikawa J-i, 1175 Kleiger RE, 361 Lehmann KG, 714 Mantica M, 1327 Moe GW, 891 Nitenberg A, 151, 514 Kleiman NS, 381, 1763 Leier CV, 201A Marburger C, 468 Mogtader A, 816 Nohara R, 1621 Kleiman RB, 1135 Leimberger JD, 1780 Marchand T, 851 Mohanty PK, 1418 North American Inoue Klein AL, 1359, 1935, 1983 Leitch JW, 1843 Marchant B, 1433 Mohiaddin RH, 1515 Balloon Investigators, 783 Klein GJ, 607, 1706, 1843, LeJemtel T, 113A Marchlinski FE, 746, 1135 Mohr BD, 1268 Nozaki A, 2022 1849 LeJemtel TH, 1399 Marcus RH, 839 Mohr WK, 1268 Nurmohamed M, 1080 Klein J, 1902 Lenders J, 1961 Margaria F, 1809 Momma K, 859 Klein LS, 1344 Leon MB, 1024, 1641 Marlow D, 95 Monrad ES, 1399 Klein LW, 1280 Leonard JV, 854 Maron BJ, 489 Montague T, 201A Oakley CM, 1653 Klein M, 390 Lesaffre E, 407 Marraccini P, 650 Montemartini C, 1614 Ochan M, 1614 2066 AUTHOR INDEX VOLUME 22 JACC Vol. 22, No. 7 December 1993:2063-7 Ockene JK, 1703 Peterson KL, 1574 REFLECT Study Principal Savage MP, 1641 Silverman DI, 221 Odake M, 598 Petrizzo A, 376 Investigators, 65 Saveliev SV, 1509 Simek CL, 251 Oddone D, 1123, 1130 Petry NA, 632 Regele B, 777 Savion N, 2001 Sinagra G, 808 Offord KP, 216 Pfeffer MA, 390 Remetz MS, 1033 Scarfo S, 1373 Sinusas AJ, 1033 Ohara Y, 291 Pfisterer M, 1446 Rendig SV, 1738 Schaff HV, 216 Siu CO, 1068 Ohman EM, 381 Pflugfelder PW, 1557 Reneman RS, 1881 Schaible T, 381 Skerl L, 1902 Okamoto M, 659 Picano E, 1809 Renlund DG, 1902 Schatz RA, 1641 Skinner JE, 557 Okay T, 1691 Pichard AD, 1024 Rhodes CG, 1653 Schechtman KB, 733, 1587 Sleight P, 73 O’Keefe JH, 690 Pietrolungo JF, 1935 Ribeiro EE, 376 Scheinman MM, 542, 741 Smith FC, 1944 O’Kelly BF, 1598 Pijls NHJ, 119 Richards DAB, 1711 Scheinowitz M, 2001 Smith G, 1189 Okin PM, 168 Pinamonti B, 808 Rickenbacher P, 1446 Scheys I, 407 Smith MD, 1494, 1530 Oliva PB, 720 Pingitore A, 1809 Ridker PM, 498 Schiele F, 1075 Smith ML, 56A Oller G, 1795 Pini R, 1873 Rigling R, 258 Schiller NB, 588, 1485, 1581 Smith SC Jr., 1574, 2033 Olson HG, 1317 Pinkerton CA, 135 Rigney DR, 557 Schlief R, 521 Smith TW, 107A, 201A Omboni S, 1866 Pinsker G, 671 Rigonan K, 1438 Schlierf G, 468 Sneddon JF, 1335 O’Neill W, 783 Pinsky JL, 6A Rimini A, 1866 Schlumpf M, 353 Sobel BE, 296, 1587 O’Neill WW, 1628 Pipilis A, 73 Ritchie M, 1170 Schmid M, 777 Sokol DK, 1068 O’Nunain S, 550 Piquard F, 1193 Rivera JM, 535 Schomig A, 521 Sole MJ, 99A Orav EJ, 201 Pire L, 1552 Roberts WC, 226, 489 Schroder R, 1304 Soler-Soler J, 1661 Oren RM, 832 Pirelli S, 1809 Robinson J, 854 Schroeder KD, 1530 Solomon SD, 498 Orlandi C, 1804 Pitt B, 3A, 158A, 201A, Rodeheffer RJ, 1921 Schuler G, 468 SOLVD Investigators, 14A, Orleans CT, 1703 204A, 1557 Roden RA, 1902 Schultz R, 1075 146A, 1403 O’Rourke RA, 1816 Planché C, 193 Rodrigo F, 399 Schiitz A, 310 Sonnenblick EH, 113A, 204A Orsinelli DA, 1679 Podrid PJ, 1773 Rodriguez A, 1060 Schutz RW, 1494 Sorensen K, 854 Osborn JL, 85, 733 Pollick C, 1994 Roig E, 1795 Schwaiger M, 368, 632, 1389, Sosa JA, 1141 Oskarsson HJ, 642 Pollock ML, 768 Roldan CA, 1269 1425 Sosa Liprandi MI, 1060 Ostrzega E, 139A Pomidossi G, 1866 Roman MJ, 1470, 1873 Schwammenthal E, 1730 Soufer R, 440 Ott DA, 1953 Ponce de Leon S, 695 Rose ML, 1378 Schwartz K, 30A Spittell JA Jr., 626 Ottani F, 417 Poole-Wilson PA, 22A, 201A, Rosen SE, 1470 Schwartz PJ, 283, 1327 Spitzer M, 1873 204A Rosenson RS, 933 Schwartz RS, 1283 Sponer G, 914 Poortermans JC, 1564 Ross DL, 1711 Schwartz SL, 907 Sra J, 921, 1718 Packer M, 3A, 65, 119A, Popma JJ, 1024 Rossen JD, 642 Schweiger C, 1821 Stanberry CD, 665 179A, 201A, 204A, 390, Port JD, 1902 Rottman J, 952 Sclavo MG, 1809 Standen JR, 968 963 Porter TR, 1418, 1858 Roubin GS, 135, 1273 Sears T, 1858 Stanford W, 832 Pagani M, 951 Ports TA, 542 Rouleau J-L, 204A, 390 Sedney MI, 1016 Stanger P, 883 Paik J, 1522 Pouleur H, 1403 Rousseau M, 14A Segal J, 449 Staples ED, 768 Palacios IF, 1060 Pouleur HG, 43A Rousseau MF, 43A, 954, 1403 Seguchi M, 859 Starling MR, 113A, 239 Palmaz JC, 2007 Power JM, 1199 Rovai D, 2014 Seidman CE, 498 Stempfle H-U, 310 Pan H-L, 1738 Powers ER, 251 Rudy Y, 2022 Serizawa T, 1175 Stern S, 671 Pandian NG, 907, 1418 Pozzati A, 417 Rumberger JA, 2060 Serra A, 1795 Stevens MJ, 1425 Paparella N, 1130, 1373 Prager NA, 85, 296 Ruocco NA, 1773 Serraf A, 193 Stevenson R, 1433 Paré M, 1795 Prates PR, 1915 Ruskin JN, 569, 1835 Sestier F, 390 Stewart WJ, 1359, 1935, 1983 Parker JO, 390 Pratt CM, 557, 1320 Rutherford BD, 690 Severi S, 1809 Stites HW, 1706, 1849 Parmley WW, 326, 623, 941, Previtali M, 1809 Ryalls M, 854 Seveso G, 1809 Stotzer T, 777 1242, 1548, 1745, 1752, Prokubovski VI, 1509 Ryan TJ, 1773, 2033 Seward JB, 1673, 1684 Strickberger SA, 1100, 1723 2055 Proschan M, 998 Ryder WA, 899 Shabetai R, 113A Strieper MJ, 594 Parry G, 1338 Przyklenk K, 302 Shah PK, 2058 Struijker Boudier HAJ, 1881 Pasternak RC, 1697 Puddu P, 417 Shah PM, 1494 Pasteuning WH, 1564 Puga FJ, 216 Saba PS, 1873 Shahidi FE, 955 Studies of Left Ventricular Patel D, 277 Saber RS, 1283 Shandas R, 1522 Dysfunction (SOLVD) Patrono C, 283 Sade RM, 183 Shannon J, 113A Investigators, 14A Patsalos PN, 1653 Quillen JE, 642 Sadun A, 251 Shapiro SM, 271 Sugimoto T, 1175 Pattee PL, 1044 Quinapril Heart Failure Trial Saeki F, 727 Sharland M, 1189 Sullivan JM, 65, 508 Patton M, 1189 Investigators, 1557 Safian RD, 1628 Sharma GVRK, 1553 Suma H, 727 Paulus WJ, 119, 954 Quinones MA, 146A Sagrista-Sauleda J, 1661 Sheehan FH, 714, 1010 Sun Y-P, 1752 Paviotti C, 1060 Quyyumi AA, 635 Sahn DJ, 1522 Sheldon R, 114 Sussex B, 390 Pawitan Y, 998 Saino A, 1866 Sherrid MV, 816 Suzuki J-i, 1175 Pearce G, 1298, 1983 Sakamoto T, 1175 Shimizu A, 2022 Symons JD, 1738 Pearce GL, 1359, 1935 Rabinovitch M, 873 Sala L, 1821 Shimizu M, 1465 Sys SU, 119, 318 Pearle DL, 65 Raciti M, 1809 Salcedo EE, 1359, 1935 Shimshak TM, 690 Szlachcic Y, 1598 Pearlman AS, 1538 Radzik D, 851 Salvati P, 283 Shinebourne E, 1189 Pecora MJ, 127 Raichlen JS, 1494 Sampathkumaran K, 1587 Shiota T, 1522 Pedini I, 1373 Raizner AE, 135 San Roman JA, 1751 Shirani J, 226 Taddei L, 2014 Pegoraro E, 1927 Rajfer SI, 198A Sanborn TA, 1273 Shotan A, 139A Tajik AJ, 1684 Penn J, 963 Ramanathan KB, 508 Sancaktar O, 1691 Shroff S, 839 Takagi T, 1647 Penn OCKM, 758 Ramaswamy K, 783 Sanders SP, 201, 1953 Shurmur S, 1858 Takahashi N, 1621 Pereira E, 1915 Rao AK, 1089 Sant’Anna JRM, 1915 Siebeck M, 1080 Takaoka H, 598 Pérez JE, 1587 Raviele A, 1123 Santoro L, 1788 Siebes M, 1068 Takeda R, 1465 Perez-Balino N, 1060 Raylman R, 1389 Sanz G, 1795 Siegel BA, 1587 Takenaka K, 1175 Permanyer-Miralda G, 1661 Raymenants E, 684 Sapin PM, 1530, 1816 Siegel RJ, 480 Takeshita A, 144, 291 Perondi R, 1866 Razzolini R, 1373 Sareli P, 826 Sievers RE, 1752 Takeuchi M, 598 Perry JC, 95 Redberg RF, 1485 Sasayama S, 1271, 1621 Sigmon KN, 1780 Taki J, 1465 Perry SB, 867 Redfield MM, 86A, 1921 Satler LF, 1024 Silling-Engelhardt G, 1080 Talley JD, 459 Peters RW, 998 Rees S, 1515 Saul JP, 1105 Silva LA, 376 Tamaki N, 1621 JACC Vol. 22, No. 7 AUTHOR INDEX VOLUME 22 December 1993:2063-7 Tamura T, 727 Trulock EP, 1170 Varetto T, 1804 Weiner DH, 146A Xie F, 1858 Tauberg SG, 127 Tsevat J, 1697 Varriale P, 1854 Weinstein MC, 1052, 1697 Xiong J, 1338 Tavares JR, 376 Tsuchioka Y, 659 Vassalli G, 1477 Weintraub R, 1522 Tavazzi L, 1821 Tubau JF, 1598 Vatner SF, 34A Weintraub RM, 1052 Taylor DO, 1418 Tucker KJ, 1485 Veen G, 1755 Weisman H, 381 Yacoub MH, 1378 Taylor M, 963 Tzivoni D, 671 Vered Z, 2001 Weiss RM, 832 Yamagata T, 659 Teerlink JR, 615 Verheugt FWA, 1755 Wellens HJJ, 758 Yamaguchi T, 727 Teirstein P, 1641 Verin VE, 1509 Wellman HN, 1344 Yamane T, 659 Temporelli PL, 1821 Udelson JE, 43A Versaci F, 1892 Welsh D, 1858 Yamanishi K, 426 Terrin ML, 1763 Uebis R, 1010 Verstraete M, 1080 Werter CJPJ, 1755 Yang B, 684 Thakur RK, 1706, 1849 Ueshima K, 175 Villanova C, 1927 Wesp AG, 1552 Yang K, 1320 Thames MD, 56A, 201A Ukmar G, 283 Villari B, 1477 Weyman AE, 535 Yee R, 607, 1706, 1843, 1849 Theisen K, 310 Ullyot DJ, 2033 Vitiello L, 1927 White HD, 707 Yellen LG, 955 Thiene G, 633 Umachandran V, 1433 Vlahakes GJ, 569, 1835 White M, 1902 Yeung-Lai-Wah J, 2061 Thomas JD, 535, 1228, 1983 Uren NG, 650, 1653 Voelker W, 777 White RD, 1935 Yip ASB, 1711 Thomas O, 854 Uretsky BF, 955 vom Dahl J, 1010 Whitlow PL, 1289, 1298 Yoganathan AP, 1730 Thoreau DH, 535 Uther JB, 1711 von Bibra H, 521 Whittaker P, 302 Yokoyama M, 598 TIMI II Investigators, 1763 Utsunomiya T, 277 Voorhees WD III, 135 Wieczorek I, 1338 Yonekura Y, 1621 TIMI Investigators, 1773 Uva MS, 193 Vorperian V, 1723 Wiedermann CJ, 1897 Yoshida K, 984, 1647 TIMI Study Group, 714 Vorperian VR, 1100 Wieland DM, 368, 1425 Yoshida N, 426 Timmis AD, 1433 Vybiral T, 557, 1320 Wijns W, 159 Yoshikawa J, 1647 Tio FO, 2007 Vaga L, 283 Willemart B, 159 Yoshio H, 1465 Tischler MD, 751 Vaitkus PT, 1004 Willems GM, 407 Young JB, 14A, 955 Tolis G Jr., 1411 Van Bortel LMAB, 1881 Wackers FJT, 407, 1033 Willerson J, 1763 Yurchak PM, 336 Tomai F, 1892 Van de Werf F, 407, 707 Waggoner AD, 1170 Williams DO, 1763 Yushak M, 963 Tomoike H, 291 van der Linden LP, 1016 Wagner J, 1304 Williams WG, 1182, 1948 Yusuf S, 3A, 14A, 146A, Tonkin AM, 1199 van der Pol JMJ, 1755 Waldo AL, 1117, 2022 Williamson B, 1100, 1723 194A, 201A Tonkon MJ, 1557 Van der Veen FH, 758 Walford GD, 1068 Wilson JR, 93A Topol EJ, 135, 381, 1228, van der Wall EE, 431 Walker CM, 1641 1289, 1780 van Doesburg N, 851 Walsh EP, 1105 Wilson M, 1159 Torchiana D, 569, 1835 van Eenige MJ, 1755 Wang FP, 1455 Wilson V, 1389 Zabel M, 2058 Torossian S, 376 van Eyll C, 1403 Wanigasekera VA, 899 Winniford MD, 642 Zanchetti A, 1866 Torr-Brown SR, 296 Van Hare GF, 542, 883 Ward DE, 550, 1335 Wisenbaugh T, 826 Zardini M, 1849 Tortorici M, 1614 van Rugge FP, 431 Wasserleben V, 665 Withagen AJAM, 1564 Zaret BL, 440, 1033, 1411 Toselli T, 99 Van Train K, 1455 Wasserman AG, 113A Wolfe ER Jr., 368, 1425 Zhang F-M, 581 Touchon RC, 113A van Veldhuisen DJ, 1564 Watanabe F, 1175 Wolff S, 498 Zhang J, 1522 Touchot A, 193 VanDellen AF, 2007 Watanabe M, 659 Wolford T, 449 Zhang Q, 1159 Tousoulis D, 1607 Vandermael M, 1289 Watkins H, 498 Wong LSS, 899 Zhu B-Q, 1752 Toussaint J-F, 1399 Vandervoort PM, 535 Webb M, 1298 Wong NLM, 891 Zipes DP, 1344 Treasure CB, 129A Vanoli E, 1327 Weber KT, 1477 Wright RS, 86A Zoble RG, 998 Triedman JK, 207 Vantrimpont PJ, 119 Weinberg SL, 328, 624, 943, Wu JM, 1751 Zuanetti G, 1788 Trivella MG, 2014 Varda-Bloom N, 2001 1266, 1549, 1746, 2056 Wunderlich W, 1304 Zwaag RV, 508 JACC Vol. 22, No. 7 December 1993:2068-84 Subject Index: Volume 22 Ablation procedures medicine, 626 Amiodarone Association between atrioventricular node Same-day surgical admission, 946 Intravenous amiodarone for life-threatening reentrant tachycardia and inducible atrial ACC Position Statement tachyarrhythmias in children and young flutter, 80 Heart rate variability for risk stratification of adults, 95 Comparison of the retrograde and transseptal life-threatening arrhythmias, 848 Prospective, randomized comparison of methods for ablation of left free wall Accessory pathways conventional and high dose loading accessory pathways, 542 See also Ablation procedures regimens of amiodarone in the treatment of Junctional tachycardia: a useful marker during Recognition and catheter ablation of ventricular tachycardia, 1723 radiofrequency ablation for atrioventricular subepicardial accessory pathways, Amlodipine node reentrant tachycardia, 1706 1100 Calcium channel blockers in heart failure, Physics and engineering of transcatheter Acetylcholine 139A cardiac tissue ablation, 921 Acetylcholine-induced constriction of Discussion VI, 145A Radiofrequency catheter ablation of angiographically normal coronary arteries Angina pectoris supraventricular arrhythmias in patients is not time dependent in transplant See also Syndrome X with congenital heart disease: results and recipients. Effects of stepwise infusion at 1, Abnormal systolic blood pressure response technical considerations, 883 6, 12 and more than 24 months after during exercise recovery in patients with Radiofrequency current delivery by way of a transplantation, 151 angina pectoris, 659 bipolar tricuspid annulus—mitral annulus ACP/ACC/AHA Task Force statement Bedside cardiology and thrombolysis electrode configuration for ablation of Clinical competence in ambulatory (editorial comment), 1317 posteroseptal accessory pathways, 550 electrocardiography, 331 Correlation of basal coronary artery tone with Recognition and catheter ablation of Clinical competence in elective direct current constrictive response to ergonovine in subepicardial accessory pathways, (DC) cardioversion, 336 patients with variant angina, 144 1100 Acute myocardial infarction Prospective comparison of unstable angina Repeated use of ablation catheters: a See Myocardial infarction versus non-Q wave myocardial infarction prospective study, 1367 Acute phase response during antithrombotic therapy, 1338 Therapeutic end points for the treatment of Myocardial injury: the acute phase response Relation between collateral channel filling and atrioventricular node reentrant tachycardia and lipoprotein metabolism, 933 flow grade in recipient coronary arteries in by catheter-guided radiofrequency current, Adenosine patients with stable effort angina, 426 733 Safety and efficacy of central intravenous Severity and response of chest pain during Abrupt closure bolus administration of adenosine for thrombolytic therapy for acute myocardial Multicenter investigation of coronary stenting termination of supraventricular infarction: a useful indicator of myocardial to treat acute or threatened closure after tachycardia, 741 salvage and infarct size, 1311 percutaneous transluminal coronary Age factors Vasotonic angina: a spectrum of ischemic angioplasty: clinical and angiographic See also Elderly syndromes involving functional outcomes, 135 Manifestations of coronary atherosclerosis in abnormalities of the epicardial and ACC/AHA Task Force Report young trauma victims—an autopsy study, microvascular coronary circulation, 417 Guidelines for percutaneous transluminal 459 Angiogenesis coronary angioplasty: A report of the Albunex Intracoronary injection of basic fibroblast American College of Cardiology/American Intracoronary air-filled albumin microspheres growth factor enhances angiogenesis in Heart Association Task Force on for myocardial blood flow measurement, infarcted swine myocardium, 2001 Assessment of Diagnostic and Therapeutic 2014 Angiography Cardiovascular Procedures (Committee on Opacification and border delineation Culprit lesion morphology and stenosis Percutaneous Transluminal Coronary improvement in patients with suboptimal severity in the prediction of reocclusion Angioplasty), 2033 endocardial border definition in routine after coronary thrombolysis: angiographic ACC Bethesda Conference Report echocardiography: results of the Phase III results of the APRICOT study, 1755 See Bethesda Conference Report Albunex Multicenter Trial, 1494 Five-year angiographic follow-up of factors ACC news Reliability of echocardiographic associated with progression of coronary President’s page: ACC Board of Trustees—a measurements of myocardial perfusion artery disease in the Coronary Artery time for change, 1266 using commercially produced sonicated Surgery Study (CASS), 1141 President’s page: A cardiology summit: the serum albumin (Albunex), 1983 Intravascular ultrasound study of ACC and the subspecialty societies Safety and efficacy of a new transpulmonary angiographically mildly diseased coronary President’s page: Doctors, placebos and a echo contrast agent in echocardiographic arteries, 1858 “letter from the king”’, 1549 studies in patients, 1193 Myocardial risk area defined by technetium- President’s page: Health care 101: the hospital Alinidine 99m sestamibi imaging during bill, 624 Short-term effects of early intravenous percutaneous transluminal coronary President’s page: Pulmonary embolism— treatment with a beta-adrenergic blocking angioplasty: comparison with coronary diagnosis on a tombstone, 328 agent or a specific bradycardiac agent in angiography, 1033 President’s page: Remembering Keats in patients with acute myocardial infarction Variability in measures of coronary lumen Rome, 943 receiving thrombolytic therapy, 407 dimensions using quantitative coronary ACC Policy Statements Alpha-adrenergic blocking agents angiography, 1068 Recommendations for development and See also specific agent Angioplasty maintenance of competence in coronary Efficacy of alpha-adrenergic agonist therapy See also Revascularization interventional procedures, 629 for prevention of pediatric Are residual stenoses after excimer laser Recommendations for training in vascular neurocardiogenic syncope, 594 angioplasty and coronary atherectomy due JACC Vol. 22, No. 7 SUBJECT INDEX: VOLUME 22 December 1993:2068-84 to inefficient or small devices? Comparison Prolonged dilation with an autoperfusion ventricular outflow tract obstruction after with balloon angioplasty, 1628 balloon catheter for refractory acute repair of interrupted aortic arch, 1953 Argentine randomized trial of percutaneous occlusion related to percutaneous Aortic disease transluminal coronary angioplasty versus transluminal coronary angioplasty, 1016 Prognostic significance of the pattern of aortic coronary artery bypass surgery in Radiation risk to patients from percutaneous root dilation in the Marfan syndrome, 1470 multivessel disease (ERACI): in-hospital transluminal coronary angioplasty, 1044 Aortic valve disease results and 1-year follow-up, 1060 Randomized trial of direct coronary Influence of collagen network on left Balloon angioplasty for postoperative angioplasty versus intravenous ventricular systolic and diastolic function pulmonary artery stenosis in transposition streptokinase in acute myocardial in aortic valve disease, 1477 of the great arteries, 859 infarction, 376 Planimetry of orifice area in aortic stenosis Beta-endorphins during coronary angioplasty Sequential intravascular ultrasound using multiplane transesophageal in patients with silent or symptomatic characterization of the mechanisms of echocardiography, 529 myocardial ischemia, 1614 rotational atherectomy and adjunct balloon Aortic valve gradient Clinical applications of coronary sinus angioplasty, 1024 Aortofemoral transfer function: a method to retroperfusion during high risk Silent ischemia after percutaneous determine the instantaneous aortic valve percutaneous transluminal coronary transluminal coronary angioplasty: gradient in aortic valve stenosis, 1909 angioplasty, 127 incidence and prognostic significance, Arrhythmias Clinical trial of percutaneous peripheral 1446 Heart rate variability for risk stratification of ultrasound angioplasty, 480 Ten-year completed follow-up of life-threatening arrhythmias (ACC Position Coronary embolization after balloon percutaneous transluminal coronary Statement), 848 angioplasty or thrombolytic therapy: an angioplasty: the early Zurich experience, Radiofrequency catheter ablation of autopsy study of 32 cases, 1283 353 supraventricular arrhythmias in patients Coronary vasoconstriction after angioplasty of Transstenotic coronary pressure gradient with congenital heart disease: results and total occlusions: relation to change in measurement in humans: in vitro and in technical considerations, 883 coronary perfusion pressure, 1635 vivo evaluation of a new pressure Arrhythmias, atrial Economics of elective coronary monitoring angioplasty guide wire, 119 Clinical, electrocardiographic and revascularization. Comparison of costs and Angiotensin-converting enzyme inhibitors morphologic features of massive fatty charges for conventional angioplasty, See also specific agent deposits (“‘lipomatous hypertrophy’’) in directional atherectomy, stenting and Discussion VII, 162A the atrial septum, 226 bypass surgery, 1052 Discussion IV, 106A Arrhythmias, ventricular Failed direct coronary angioplasty for acute Discussion IX, 192A Asymptomatic ventricular arrhythmias and myocardial infarction: in-hospital outcome Efficacy of phosphodiesterase inhibition with mortality risk in subjects with left and predictors of death, 690 milrinone in combination with converting ventricular hypertrophy, 1111 Guidelines for percutaneous transluminal enzyme inhibitors in patients with heart Defibrillation shocks produce different effects coronary angioplasty: a report of the failure, 113A on Purkinje fibers and ventricular muscle: American College of Cardiology/American Relation of pathophysiologic mechanisms to implications for successful defibrillation, Heart Association Task Force on outcome in heart failure, 22A refibrillation and postshock arrhythmia, Assessment of Diagnostic and Therapeutic Role of converting enzyme inhibitors in the 607 Cardiovascular Procedures (Committee on treatment of heart failure, 154A Aspirin Percutaneous Transluminal Coronary Sustained hemodynamic response to Inhibitory effects of heparin, aspirin and Angioplasty), 2033 flosequinan in patients with heart failure ketanserin on coronary artery High pressure balloon angioplasty for branch receiving angiotensin-converting enzyme vasoconstriction after arterial balloon pulmonary artery stenosis: early inhibitors, 963 injury in hypercholesterolemic miniature experience, 867 Use of converting enzyme inhibitors in pigs, 291 Inhibitory effects of heparin, aspirin and patients with asymptomatic left ventricular Profound inhibition of platelet aggregation ketanserin on coronary artery dysfunction, 158A with monoclonal antibody 7E3 Fab after vasoconstriction after arterial balloon Antiheart antibodies thrombolytic therapy. Results of the injury in hypercholesterolemic miniature Concepts of autoimmunity applied to Thrombolysis and Angioplasty in pigs, 291 idiopathic dilated cardiomyopathy Myocardial Infaction (TAMI) 8 Pilot Is traditionally defined complete (editorial comment), 1385 Study, 381 revascularization needed for patients with Frequency and specificity of antiheart Verapamil and aspirin modulate platelet- multivessel disease treated by elective antibodies in patients with dilated mediated vasomotion in arterial segments coronary angioplasty?, 1289 cardiomyopathy detected using SDS-Page with intact or disrupted endothelium, 684 Mechanisms of cardiac pain during coronary and Western blotting, 1378 Atenolol angioplasty, 1892 Antiarrhythmic drug therapy Short-term effects of early intravenous Multicenter investigation of coronary stenting See also specific agent treatment with a beta-adrenergic blocking to treat acute or threatened closure after Multiple monomorphic ventricular agent or a specific bradycardiac agent in percutaneous transluminal coronary tachycardia configurations predict failure patients with acute myocardial infarction angioplasty: clinical and angiographic of antiarrhythmic drug therapy guided by receiving thrombolytic therapy, 407 outcomes, 135 electrophysiologic study, 1117 Atherectomy Novel strategy for stent deployment in the Antiphospholipid antibodies Are residual stenoses after excimer laser treatment of acute or threatened closure Antiphospholipid antibodies and valve disease angioplasty and coronary atherectomy due complicating balloon coronary angioplasty. in patients with systemic lupus to inefficient or small devices? Comparison Use of short or standard (or both) single or erythematosus (letter), 1269 with balloon angioplasty, 1628 multiple Palmaz-Schatz stents, 1887 Antithrombotic therapy Economics of elective coronary Percutaneous angioplasty of stenosed See also specific agent revascularization. Comparison of costs and gastroepiploic artery grafts, 727 Prospective comparison of unstable angina charges for conventional angioplasty, Percutaneous transluminal coronary versus non-Q wave myocardial infarction directional atherectomy, stenting and angioplasty of one major coronary artery during antithrombotic therapy, 1338 bypass surgery, 1052 when the contralateral vessel is occluded, Aortic arch Sequential intravascular ultrasound 1298 Echocardiographic predictors of left characterization of the mechanisms of 2070 SUBJECT INDEX: VOLUME 22 JACC Vol. 22, No. 7 December 1993:2068-84 rotational atherectomy and adjunct balloon Impact of electrical cardioversion for atrial Baroreflex angioplasty, 1024 fibrillation on left atrial appendage Abnormalities of baroreflex control in heart Atherosclerosis function and spontaneous echo contrast: failure, 56A Acetylcholine-induced constriction of characterization by simultaneous Impairment of the arterial baroreflex during angiographically normal coronary arteries transesophageal echocardiography, symptomatic and silent myocardial is not time dependent in transplant 1359 ischemia in humans, 1866 recipients. Effects of stepwise infusion at 1, Atrial natriuretic factor Bedside examination 6, 12 and more than 24 months after Atrial natriuretic peptide in heart failure, Bedside cardiovascular examination in transplantation, 151 86A patients with severe chronic heart failure: Acute and chronic effects of smoking on Discussion IV, 106A importance of rest or inducible jugular arterial wall properties in habitual smokers, Dual natriuretic peptide system in venous distension, 968 Dec. experimental heart failure, 891 Beta-adrenergic blocking agents Effects of exercise on coronary atherosclerotic Plasma atrial natriuretic peptide response to See specific agent lesions (editorial comment), 478 direct current cardioversion of atrial Beta-adrenergic receptors Increased experimental atherosclerosis in fibrillation in patients with mitral stenosis, Changes in myocardial and vascular receptors cholesterol-fed rabbits exposed to passive 575 in heart failure, 61A smoke: taking issues with study design and Atrial septal defect Diffuse reduction of myocardial beta- methods of analysis (letter), 1751 Predictive factors for spontaneous closure of adrenoceptors in hypertrophic Manifestations of coronary atherosclerosis in atrial septal defects diagnosed in the first 3 cardiomyopathy: a study with positron young trauma victims—an autopsy study, months of life, 851 emission tomography, 1653 459 Three-dimensional ultrasound imaging of the Discussion III, 85A Toward the quiescent coronary plaque, 1228 atrial septum: normal and pathologic Up-regulation of beta,-adrenergic receptors in Various intensities of leisure time physical anatomy, 1673 previously transplanted, denervated activity in patients with coronary artery Atrial size nonfailing human hearts, 1902 disease: effects on cardiorespiratory fitness Changes in left and right atrial size after Bethesda Conference Report and progression of coronary atherosclerotic cardioversion of atrial fibrillation: role of 24th Bethesda Conference: Cardiac lesions, 468 mitral valve disease, 1666 Transplantation, | Atrial arrhythmias Estimation of left ventricular filling pressures Blood flow See Arrhythmias, atrial using two-dimensional and Doppler Active compression-decompression Atrial contraction echocardiography in adult patients with resuscitation: analysis of transmitral flow Estimation of left ventricular filling pressures cardiac disease. Additional value of and left ventricular volume by using two-dimensional and Doppler analyzing left atrial size, left atrial ejection transesophageal echocardiography in echocardiography in adult cardiac patients fraction and the difference in the duration humans, 1485 with cardiac disease. Additional value of of pulmonary venous and mitral flow Assessing the hemodynamic significance of analyzing left atrial size, left atrial ejection velocity at atrial contraction, 1972 coronary artery stenoses: analysis of fraction and the difference in the duration Atrial tachycardia translesional pressure—flow velocity of pulmonary venous and mitrai flow Long-term effectiveness of surgical treatment relations in patients, 449 velocity at atrial contraction, 1972. of ectopic atrial tachycardia, 85 Automated flow rate calculations based on Atrial fibrillation/flutter Management of ectopic atrial tachycardia digital analysis of flow convergence Association between atrioventricular node (editorial comment), 93 proximal to regurgitant orifices, 535 reentrant tachycardia and inducible atrial Atrioventricular node Calculation of volume flow rate by the flutter, 80 See also Ablation procedures proximal isovelocity surface area method: Atrial fibrillation: current understandings and Elimination of slow pathway conduction: an simplified approach using color Doppler research imperatives, 1830 accurate indicator of clinical success after zero baseline shift, 277 Changes in left and right atrial size after radiofrequency atrioventricular node Cardiac motion can alter proximal isovelocity cardioversion of atrial fibrillation: role of modification, 1849 surface area calculations of regurgitant mitral valve disease, 1666 Experimentally created atrioventricular node flow, 1730 Characterization of double potentials in a reentrant tachycardia in the dog: evidence Determination of mitral regurgitant flow rate functionally determined reentrant circuit. of a brake system for nodal reentry in the from color flow maps of the regurgitant Multiplexing studies during interruption of anterior interatrial septum, 1541 flow convergence region (letter), 1554 atrial flutter in the canine pericarditis Autoimmunity Estimation of left ventricular filling pressures model, 2022 Concepts of autoimmunity applied to using two-dimensional and Doppler Impact of electrical cardioversion for atrial idiopathic dilated cardiomyopathy echocardiography in adult patients with fibrillation on left atrial appendage (editorial comment), 1385 cardiac disease. Additional value of function and spontaneous echo contrast: Frequency and specificity of antiheart analyzing left atrial size, left atrial ejection characterization by simultaneous antibodies in patients with dilated fraction and the difference in the duration transesophageal echocardiography, 1359 cardiomyopathy detected using SDS-Page of pulmonary venous and mitral flow Importance of electrode design, lead and Western blotting, 1378 velocity at atrial contraction, 1972 configuration and impedance for successful Autonomic nervous system Influence of heparin and systemic lysis on low energy transcatheter atrial Pharmacologic modulation of the autonomic coronary blood flow after reperfusion defibrillation in dogs, 1199 nervous system in the prevention of sudden induced by the novel recombinant Plasma atrial natriuretic peptide response to cardiac death. A study with propranolol, plasminogen activator BM 06.022 in a direct current cardioversion of atrial methacholine and oxotremorine in canine model of coronary thrombosis, 914 fibrillation in patients with mitral stenosis, conscious dogs with a healed myocardial Intracoronary air-filled albumin microspheres 575 infarction, 283 for myocardial blood flow measurement, Role of autonomic reflexes in syncope Role of autonomic reflexes in syncope 2014 associated with paroxysmal atrial associated with paroxysmal atrial Magnetic resonance volume flow and jet fibrillation, 1123 fibrillation, 1123 velocity mapping in aortic coarctation, Atrial function Silent myocardial ischemia: role of subclinical 1515 Atrial ejection force: a noninvasive neuropathy in patients with and without Regional specificity of peak hyperemic assessment of atrial systolic function, 221 diabetes, 1433 response in patients with congestive heart JACC Vol. 22, No. 7 SUBJECT INDEX: VOLUME 22 December 1993:2068-84 failure: correlation with peak aerobic humans, 368 another form of ischemic cardiomyopathy? capacity, 1399 Cardiac arrest (editorial comment), 805 Relation between collateral channel filling and See also Sudden death Left ventricular hypertrophy and morphology flow grade in recipient coronary arteries in Myocardial ischemia detected by thallium in familial hypertrophic cardiomyopathy patients with stable effort angina, 426 scintigraphy is frequently related to cardiac associated with mutations of the beta- Vasotonic angina: a spectrum of ischemic arrest and syncope in young patients with myosin heavy chain gene, 498 syndromes involving functional hypertrophic cardiomyopathy, 796 Molecular echocardiography (editorial abnormalities of the epicardial and Cardiac catheterization comment), 506 microvascular coronary circulation, 417 Multipolar endocardial mapping of the right Myocardial ischemia detected by thallium Blood pressure atrium during cardiac catheterization: scintigraphy is frequently related to cardiac See also Hypertension description of a new technique, 1105 arrest and syncope in young patients with Abnormal systolic blood pressure response Cardiac conduction hypertrophic cardiomyopathy, 796 during exercise recovery in patients with Elimination of slow pathway conduction: an Natural history of idiopathic dilated angina pectoris, 659 accurate indicator of clinical success after cardiomyopathy: effect of referral bias and Relation of arterial pressure waveform to left radiofrequency atrioventricular node secular trend, 1921 ventricular and carotid anatomy in modification, 1849 New subtype of apical hypertrophic normotensive subjects, 1873 Cardiac motion cardiomyopathy identified with nuclear BM 06.022 Cardiac motion can alter proximal isovelocity magnetic resonance imaging as an Influence of heparin and systemic lysis on surface area calculations of regurgitant underlying cause of markedly inverted T coronary blood flow after reperfusion flow, 1730 waves, 1175 induced by the novel recombinant Influence of cardiac motion on Doppler Restrictive left ventricular filling pattern in plasminogen activator BM 06.022 in a measurements using in vitro and in vivo dilated cardiomyopathy assessed by canine model of coronary thrombosis, 914 models, 271 Doppler echocardiography: clinical, Books received, 634 Cardiac pain echocardiographic and hemodynamic Bradycardia Mechanisms of cardiac pain during coronary correlations and prognostic implications, Abnormal neural reflex plays a role in causing angioplasty, 1892 808 syncope in sinus bradycardia, 1130 Cardiac rehabilitation Viral myocarditis: a paradigm for Bradycardiac agents Benefits of cardiac rehabilitation and exercise understanding the pathogenesis and See specific agent training in secondary coronary prevention treatment of dilated cardiomyopathy, 99A Brain natriuretic factor in the elderly, 678 Cardiomyoplasty Dual natriuretic peptide system in Discussion VIII, 178A Long-term follow-up (12 to 35 weeks) after experimental heart failure, 891 Exercise rehabilitation in chronic heart failure, dynamic cardiomyoplasty, 758 Bundle branch block 172A Cardiopulmonary resuscitation Right bundle branch block, persistent ST Cardiac tamponade Active compression-decompression segment elevation and sudden cardiac Left ventricular diastolic collapse in regional resuscitation: analysis of transmitral flow death (letter), 633 left heart cardiac tamponade. An and left ventricular volume by BW755C experimental echocardiographic and transesophageal echocardiography in Limitation of myocardial infarct size in pigs hemodynamic study, 907 humans, 1485 with a dual lipoxygenase-cyclooxygenase Cardiac transplantation Cardioversion blocking agent by inhibition of neutrophil See Heart transplantation Changes in left and right atrial size after activity without reduction of neutrophil Cardiomyopathy cardioversion of atrial fibrillation: role of migration, 1738 See also Hypertrophy mitral valve disease, 1666 Acute effects of dobutamine on myocardial Clinical competence in elective direct current Calcium channel blocking agents oxygen consumption and cardiac efficiency (DC) cardioversion, 336 See also specific agent measured using carbon-11 acetate kinetics Impact of electrical cardioversion for atrial Calcium channel blockers in heart failure, in patients with dilated cardiomyopathy, fibrillation on left atrial appendage 139A 1389 function and spontaneous echo contrast: Discussion VI, 145A Coexistence of sudden cardiac death and characterization by simultaneous Captopril end-stage heart failure in familial transesophageal echocardiography, 1359 Captopril potentiates the effects of hypertrophic cardiomyopathy, 489 Plasma atrial natriuretic peptide response to nitroglycerin in the coronary vascular bed, Concepts of autoimmunity applied to direct current cardioversion of atrial 581 idiopathic dilated cardiomyopathy fibrillation in patients with mitral stenosis, Hemodynamic effects of captopril and (editorial comment), 1385 575 isosorbide mononitrate started early in Differentiation of constrictive pericarditis Cardioverter-defibrillator acute myocardial infarction: a randomized from restrictive cardiomyopathy by Determinants of successful nonthoracotomy placebo-controlled study, 73 Doppler transesophageal cardioverter-defibrillator implantation: Carbon-11 acetate echocardiographic measurements of experience in 101 patients using two Acute effects of dobutamine on myocardial respiratory variations in pulmonary venous different lead systems, 1835 oxygen consumption and cardiac efficiency flow, 1935 Successful implantation of cardioverter- measured using carbon-11 acetate kinetics Diffuse reduction of myocardial beta- defibrillator systems in patients with in patients with dilated cardiomyopathy, adrenoceptors in hypertrophic elevated defibrillation thresholds, 569 1389 cardiomyopathy: a study with positron Unique sensing errors in third-generation Comparison of carbon-11 acetate with emission tomography, 1653 implantable cardioverter-defibrillators, fluorine-18 fluorodeoxyglucose for Echocardiographic study of the fluid 1135 delineating viable myocardium by positron mechanics of obstruction in hypertrophic Use of a regional wall motion score to enhance emission tomography, 1587 cardiomyopathy, 816 risk stratification of patients receiving an Carbon-11 hydroxyephedrine Frequency and specificity of antiheart implantable cardioverter-defibrillator, Carbon-11 hydroxyephedrine with positron antibodies in patients with dilated 1093 emission tomography for serial assessment cardiomyopathy detected using SDS-Page Carditis of cardiac adrenergic neuronal function and Western blotting, 1378 See also Endocarditis; Myocarditis; after acute myocardial infarction in Hypertrophic cardiomyopathy in the young: Pericarditis 2072 SUBJECT INDEX: VOLUME 22 JACC Vol. 22, No. 7 December 1993:2068-84 Congestive heart failure in rheumatic carditis: syndrome: phenotypic diagnosis and graphy or scintigraphy, or both?, 159 valvular or myocardial origin? (editorial echocardiographic assessment of 118 Relation between collateral channel filling and comment), 830 patients, 1189 flow grade in recipient coronary arteries in Evidence against a myocardial factor as the Echocardiographic morphometry and patients with stable effort angina, 426 cause of left ventricular dilation in active geometry of the left ventricular outflow Role of behavioral and psychological factors rheumatic carditis, 826 tract in fixed subaortic stenosis, 1501 in mental stress—induced silent left Carotid artery Individual pulmonary vein size and survival in ventricular dysfunction in coronary artery Relation of arterial pressure waveform to left infants with totally anomalous pulmonary disease, 440 ventricular and carotid anatomy in venous connection, 201 Coronary artery patency normotensive subjects, 1873 Influence of ventricular morphology on Influence of infarct-related artery patency on Catheter diastolic filling performance in double- the indexes of parasympathetic activity and See Ablation procedures inlet ventricle after the Fontan procedure, prevalence of late potentials in survivors of Prolonged dilation with an autoperfusion 1948 acute myocardial infarction, 695 balloon catheter for refractory acute Outcomes in critically ill neonates with Maintenance of patency after thrombolysis in occlusion related to percutaneous pulmonary stenosis and intact ventricular stenotic coronary arteries requires transluminal coronary angioplasty, 1016 septum: a multiinstitutional study, 183 combined inhibition of thrombin and Repeated use of ablation catheters: a Predictive factors for spontaneous closure of platelets, 296 prospective study, 1367 atrial septal defects diagnosed in the first 3 Coronary artery tone Catheterization months of life, 851 Correlation of basal coronary artery tone with See Cardiac catheterization Radiofrequency catheter ablation of constrictive response to ergonovine in Cineventriculography supraventricular arrhythmias in patients patients with variant angina, 144 Three-dimensional echocardiographic with congenital heart disease: results and Coronary blood flow measurement of left ventricular volume in technical considerations, 883 See Blood flow vitro: comparison with two-dimensional Scimitar syndrome in infancy, 873 Coronary dissection echocardiography and Contractile function Novel strategy for stent deployment in the cineventriculography, 1530 Evidence against a myocardial factor as the treatment of acute or threatened closure Circadian rhythm cause of left ventricular dilation in active complicating balloon coronary angioplasty. Identification of a secondary peak in rheumatic carditis, 826 Use of short or standard (or both) single or myocardial infarction onset 11 to 12 hours Impaired left ventricular contractile function multiple Palmaz-Schatz stents, 1887 after awakening: the Cardiac Arrhythmia in patients with long-term mitral Coronary flow reserve Suppression Trial (CAST) experience, 998 regurgitation and normal ejection fraction, Altered coronary vasodilator reserve and Coarctation of the aorta 239 metabolism in myocardium subtended by Magnetic resonance volume flow and jet Left ventricular hypercontractility and ST normal arteries in patients with coronary velocity mapping in aortic coarctation, segment depression in patients with artery disease, 650 1515 syndrome X, 1607 Coronary vascular mechanisms involved in Cocaine Coronary artery disease decompensation from hypertrophy to heart Left ventricular function immediately after Altered coronary vasodilator reserve and failure, 34A intravenous cocaine: a quantitative two- metabolism in myocardium subtended by Coronary vasodilator reserve in untreated and dimensional echocardiographic study, normal arteries in patients with coronary treated hypertensive patients with and 1581 artery disease, 650 without left ventricular hypertrophy, 514 Collagen Angiogenic effects of low molecular weight Discussion II, 41A Influence of collagen network on left heparin in patients with stable coronary Coronary occlusion ventricular systolic and diastolic function artery disease: a pilot study, 635 Fate of lesion-related side branches after in aortic valve disease, 1477 Benefits of cardiac rehabilitation and exercise coronary artery stenting, 1641 Multicenter randomized trial comparing a training in secondary coronary prevention Novel strategy for stent deployment in the percutaneous collagen hemostasis device in the elderly, 678 treatment of acute or threatened closure with conventional manual compression Dobutamine stress magnetic resonance complicating balloon coronary angioplasty. after diagnostic angiography and imaging for detection of coronary artery Use of short or standard (or both) single or angioplasty, 1273 disease, 431 multiple Palmaz-Schatz stents, 1887 Utility of a percutaneous collagen hemostasis Estimating probability of coronary artery Percutaneous transluminal coronary device: to plug or not to plug (editorial disease (letter), 340 angioplasty of one major coronary artery comment), 1280 Five-year angiographic follow-up of factors when the contralateral vessel is occluded, Collateral vessels associated with progression of coronary 1298 Angiogenic effects of low molecular weight artery disease in the Coronary Artery Prolonged dilation with an autoperfusion heparin in patients with stable coronary Surgery Study (CASS), 1141 balloon catheter for refractory acute artery disease: a pilot study, 635 Impaired endothelial function occurs in the occlusion related to percutaneous Assessing collateral development after acute systemic arteries of children with transluminal coronary angioplasty, 1016 myocardial infarction (letter), 1270 homozygous homocystinuria but not in Coronary perfusion Prevalence and risk factors for their heterozygous parents, 854 See also Myocardial perfusion aortopulmonary collateral vessels after Independent and incremental prognostic value Clinical applications of coronary sinus Fontan and bidirectional Glenn procedures, of exercise single-photon emission retroperfusion during high risk 207 computed tomographic (SPECT) thallium percutaneous transluminal coronary Relation between collateral channel filling and imaging in coronary artery disease, 665 angioplasty, 127 flow grade in recipient coronary arteries in Intravascular ultrasound study of Coronary vasoconstriction after angioplasty of patients with stable effort angina, 426 angiographically mildly diseased coronary total occlusions: relation to change in Conduction arteries, 1858 coronary perfusion pressure, 1635 See Cardiac conduction Measurement variables for optimal Corrections Congenital heart defects performance of the ST integral, 168 Brutsaert DL, Sys SU, Gillebert TC. Diastolic See also Pediatric cardiology; specific defect; Optimal use of dobutamine stress for the failure: pathophysiology and therapeutic Surgery, pediatric detection and evaluation of coronary artery implications. J Am Coll Cardiol Cardiologic abnormalities in Noonan disease: combination with echocardio- 1993;22:318-25, 1272